The board of directors Merck (NYSE:MRK) authorised a dividend of USD0.65 per share of the company's common stock for the third quarter of 2021, it declared on Tuesday.
This dividend is payable on 7 July 2021 to shareholders of record at the close of business as of 15 June 2021.
According to the biopharmaceutical company, it has been bringing forward medicines and vaccines for many of the world's most challenging diseases and is at the forefront of research to prevent and treat diseases including cancer, HIV and Ebola.
genedrive secures initial overseas orders for Genedrive MT-RNR1 ID kit
Kromek collaborates on next-gen CT detector technology
Gilead Sciences initiates Phase 2 trial in Europe to evaluate lenacapavir for HIV prevention
European Commission grants authorisation to ViiV Healthcare's Apretude for prevention of HIV
Celanese to supply VitalDose drug delivery platform for Population Council's MPT Intravaginal Ring
Henry Schein introduces equipment repair subscription - Henry Schein Thrive Service Plus
Seres Therapeutics provides business updates and reports Q2 2023 financial results